Arena obesity pill wins over U.S. advisers (Reuters, 10 May 2012)

14 May 2012


The US Endocrinologic and Metabolic Drugs Advisory Committee has provided a positive opinion to the FDA to approve the marketing application for lorcaserin for weight management in obese and overweight patients.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story